Monthly report from the EU Pharmacovigilance Risk Assessment Committee (PRAC) - June 2013

19 June 2013

The EU Pharmacovigilance Risk Assesment Committee (PRAC) convened on 10-13 June 2013. Among the topics discussed at the meeting were:

  • PRAC recommends restricting use of codeine when used for pain relief in children
  • PRAC recommendation on diclofenac
  • PRAC recommends suspension of hydroxyethyl-starch-containing solution for infusion
  • PRAC recommendation on flupirtine-containing medicines
  • New referral procedure for Numeta G13%E and G16%E

Please see the PRAC's monthly report: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 June 2013